Law360
Assessing FDA Pathways For Genome-Edited Plant Foods
March 21, 2024
In February, the U.S. Food and Drug Administration clarified the regulatory pathway for foods produced from genome-edited plants in the form of a final guidance issued by the agency's Center for Food Safety and Applied Nutrition and Center for Veterinary Medicine, titled "Foods Derived from Plants Produced Using Genome Editing." In this article, Sidley analyzes the paths forward that are available.
Contacts
Capabilities
Suggested News & Insights
A New World Order – Market Access, MFN, and GeopoliticsTuesday, November 10, 2026Sidley & Trinity Capital Life Sciences ReceptionThursday, October 22, 2026California Adopts Regulations Expanding Healthcare Transaction ReviewOctober 8, 20262025 to First-Half 2026 Marks a Breakout Time for CVRsOctober 7, 2026Sidley Represents GE HealthCare in Its US$945 Million Acquisition of SOFIE BiosciencesOctober 7, 2026A Breakout Year for CVRs: 2025 and First-Half 2026 Trends in Life Sciences Public M&AOctober 6, 2026
- Stay Up To DateSubscribe to Sidley Publications
- Follow Sidley on Social MediaSocial Media Directory

